This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld

c-Myc and Rel/NF-{kappa}B Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells
J. Virol. Faumont et al. 83: 5014

Supplemental material

Files in this Data Supplement:

  • Supplemental file 1 - Fig. S1 (Class 1 genes moderately downregulated in a similar fashion in both c-Myc and EBV latency III-driven proliferating cells during the transition from resting to proliferating state.)
    Fig. S2 (Class 2 genes markedly decreased in c-Myc-driven proliferating cells and moderately in EBV latency III-driven proliferating cells during the transition from resting to proliferating state.)
    Fig. S3 (Class 3 genes specifically repressed in the c-Myc program during the transition from resting to proliferating state.)
    Fig. S4 (Class 5 genes specifically expressed in the c-Myc program during the transition from resting to proliferating state.)
    Fig. S5 (Class 6 genes markedly induced in both the EBV latency III and the c-Myc proliferating programs during the transition from resting to proliferating state.)
    Fig. S6 (Class 7 genes specifically expressed in the EBV latency III proliferating program during the transition from resting to proliferating state.)
    Fig. S7 (Class 8 genes specifically induced in the EBV latency III proliferating program and unchanged in the c-Myc program during the transition from resting to proliferating state.)
    Fig. S8 (Class 9 genes specifically induced in the EBV latency III proliferating program and repressed in the c-Myc program during the transition from resting to proliferating state.)
    Fig. S9 (Class 10 genes weakly induced in the EBV latency III program and repressed in the c-Myc program during the transition from resting to proliferating state.)
    MS Word document, 367 K.
  • Supplemental file 2 - Fig. S10 (Validation of EBV gene expression.)
    MS Word document, 1.25 MB




This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld